Adicet Bio (ACET) Interest Income - Total (2024 - 2026)
Adicet Bio (ACET) posted quarterly Interest Income - Total of $1.3 million for Q1 2026, down 20.26% year-over-year from $1.7 million in Q1 2025, and down 11.94% quarter-over-quarter from $1.5 million in Q4 2025.
Adicet Bio (ACET) Interest Income - Total (2024 - 2026) Analysis & Trends
Adicet Bio's Interest Income - Total history runs 3 years deep, the most recent figure standing at $1.3 million for Q1 2026.
- In Q1 2026, Interest Income - Total fell 20.26% year-over-year to $1.3 million; the TTM figure through Mar 2026 stood at $5.4 million (down 42.65% YoY), while the FY2025 annual figure was $5.8 million, down 46.08% from the prior year.
- Interest Income - Total for Q1 2026 stood at $1.3 million, down from $1.5 million in the prior quarter.
- The five-year high for Interest Income - Total was $3.0 million in Q2 2024, with the low at $1.2 million in Q3 2025.
- The 3-year median for Interest Income - Total is $1.7 million (2025), against an average of $2.0 million.
- The sharpest annual moves came in 2025 and 2026: Interest Income - Total tumbled 57.07% in 2025, then fell 20.26% in 2026.
- Adicet Bio's Interest Income - Total stood at $2.1 million in 2024, then retreated by 26.27% to $1.5 million in 2025, then retreated by 11.94% to $1.3 million in 2026.
- Business Quant data shows ACET's Interest Income - Total at $1.3 million in Q1 2026, $1.5 million in Q4 2025, and $1.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Income - Total (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Adicet Bio | 98.21 Mn | -19.98 Mn | - | 1.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.17 Mn |
| Jun 30, 2026 | 1.17 Mn |
| Mar 31, 2026 | 1.34 Mn |
| Mar 31, 2026 | 1.34 Mn |
| Dec 31, 2025 | 1.52 Mn |
| Dec 31, 2025 | 1.52 Mn |
| Sep 30, 2025 | 1.17 Mn |
| Sep 30, 2025 | 1.17 Mn |
| Jun 30, 2025 | 1.40 Mn |
| Jun 30, 2025 | 1.40 Mn |
| Mar 31, 2025 | 1.68 Mn |
| Mar 31, 2025 | 1.68 Mn |
| Dec 31, 2024 | 2.07 Mn |
| Dec 31, 2024 | 2.07 Mn |
| Sep 30, 2024 | 2.73 Mn |
| Sep 30, 2024 | 2.73 Mn |
| Jun 30, 2024 | 3.00 Mn |
| Jun 30, 2024 | 3.00 Mn |
| Mar 31, 2024 | 2.92 Mn |
| Mar 31, 2024 | 2.92 Mn |